This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| COVID-19 | 524 |
| SARS | 263 |
| CoV-2 | 204 |
| Hospital | 194 |
| China | 163 |
| CT | 111 |
| Wuhan | 102 |
| ICU | 84 |
| Coronavirus | 79 |
| TB | 78 |
| MERS | 71 |
| COPD | 65 |
| CoV | 60 |
| Clinical | 49 |
| People | 49 |
| Respiratory | 48 |
| Disease | 48 |
| Health | 45 |
| Respir | 44 |
| J | 44 |
| Italy | 42 |
| Eur | 42 |
| DOI | 42 |
| PCR | 38 |
| ACE-2 | 36 |
| ARDS | 36 |
| University | 35 |
| LCO | 35 |
| sha | 34 |
| D | 34 |
| HFNO | 32 |
| Covid-19 | 32 |
| CAPA | 32 |
| NIV | 31 |
| East | 30 |
| HFNC | 29 |
| Li | 29 |
| Society | 28 |
| Middle | 28 |
| March | 28 |
| RT | 27 |
| IgA | 27 |
| Syndrome | 26 |
| National | 26 |
| Medical | 26 |
| Novel | 25 |
| NRS | 25 |
| County | 23 |
| Table | 23 |
| UK | 23 |
| Central | 21 |
| BAL | 21 |
| Pneumonia | 21 |
| IgG | 20 |
| CPAP | 19 |
| Affiliated | 19 |
| CO | 19 |
| Hubei | 19 |
| Patients | 19 |
| Study | 19 |
| Shenzhen | 18 |
| K | 18 |
| First | 18 |
| NCCID | 17 |
| GM | 17 |
| CsA | 17 |
| Chest | 16 |
| ACE2 | 16 |
| Characteristics | 16 |
| France | 16 |
| ICS | 16 |
| Risk | 16 |
| IgM | 15 |
| Care | 15 |
| Commission | 15 |
| IQR | 15 |
| World | 15 |
| January | 15 |
| Model | 15 |
| Thoracic | 15 |
| AUROC | 14 |
| A | 14 |
| WHO | 13 |
| Pandemic | 13 |
| Organization | 13 |
| New | 13 |
| Group | 13 |
| February | 13 |
| District | 12 |
| HR | 12 |
| Figure | 12 |
| Imaging | 12 |
| CRP | 12 |
| COVID19 | 12 |
| Analysis | 12 |
| II | 12 |
| Yang | 12 |
| Impact | 12 |
| Lombardy | 12 |
| R | 12 |
| Report | 12 |
| Supplementary | 12 |
| Treatment | 12 |
| United | 12 |
| L | 12 |
| Infection | 11 |
| CI | 11 |
| Calu-3 | 11 |
| Diagnosis | 11 |
| European | 11 |
| IRF1 | 11 |
| CFTR | 11 |
| Influenza | 11 |
| MS | 11 |
| Medicine | 11 |
| Mortality | 11 |
| PE | 11 |
| Second | 11 |
| Liu | 11 |
| Management | 10 |
| April | 10 |
| Bronchoscopy | 10 |
| Chongqing | 10 |
| College | 10 |
| Distress | 10 |
| Guidelines | 10 |
| HAPE | 10 |
| Prediction | 10 |
| N | 10 |
| Pulmonary | 10 |
| States | 10 |
| Tuberculosis | 10 |
| Units | 10 |
| Wang | 10 |
| Zhang | 10 |
| −1 | 10 |
| COVID | 9 |
| 8) | 9 |
| Acute | 9 |
| Associated | 9 |
| LDH | 9 |
| Chen | 9 |
| IA | 9 |
| ETI | 9 |
| Global | 8 |
| Aspergillosis | 8 |
| Association | 8 |
| C | 8 |
| Cox | 8 |
| DNI | 8 |
| Europe | 8 |
| Fisher | 8 |
| CF | 8 |
| ICUs | 8 |
| JAK | 8 |
| May | 8 |
| RNA | 8 |
| Use | 8 |
| VTE | 8 |
| mg | 8 |
| st | 8 |
| III | 8 |
| December | 7 |
| IFN | 7 |
| Hui | 7 |
| Hospitalized | 7 |
| Hong | 7 |
| Hangzhou | 7 |
| Africa | 7 |
| Cancer | 7 |
| CTPA | 7 |
| B | 7 |
| Age | 7 |
| AI | 7 |
| IV | 7 |
| ISARIC | 7 |
| Zhong | 7 |
| Infectious | 7 |
| Wei | 7 |
| ± | 7 |
| min | 7 |
| meta | 7 |
| • | 7 |
| Xiao | 7 |
| M. | 7 |
| Virus | 7 |
| Trial | 7 |
| Score | 7 |
| Region | 7 |
| Paris | 7 |
| US | 7 |
| City | 6 |
| Findings | 6 |
| Evaluation | 6 |
| Editorial | 6 |
| ERS | 6 |
| Cyclosporin | 6 |
| Control | 6 |
| Asthma | 6 |
| Case | 6 |
| CXR | 6 |
| American | 6 |
| AUC | 6 |
| ALV | 6 |
| Guangzhou | 6 |
| G | 6 |
| Development | 6 |
| HIV | 6 |
| NP | 6 |
| IQOS | 6 |
| York | 6 |
| Pressure | 6 |
| PSI | 6 |
| PM | 6 |
| OP | 6 |
| Non | 6 |
| Patient | 6 |
| Marie | 6 |
| Intensive | 6 |
| Liang | 6 |
| Journal | 6 |
| Jie | 6 |
| Lung | 6 |
| Deepak | 5 |
| Drs | 5 |
| Early | 5 |
| Expert | 5 |
| FOV | 5 |
| Features | 5 |
| Factors | 5 |
| Fourth | 5 |
| Giovanni | 5 |
| CypA | 5 |
| H1N1 | 5 |
| D. | 5 |
| BALF | 5 |
| Commercial | 5 |
| CoV2 | 5 |
| Chinese | 5 |
| C. | 5 |
| British | 5 |
| Bos | 5 |
| Arabia | 5 |
| America | 5 |
| Airway | 5 |
| ATS | 5 |
| < | 5 |
| IPA | 5 |
| IAPA | 5 |
| Francesco | 5 |
| Ill | 5 |
| Review | 5 |
| hypoxaemia | 5 |
| Zhi | 5 |
| Zealand | 5 |
| Yu | 5 |
| Yi | 5 |
| Yan | 5 |
| Tao | 5 |
| Spain | 5 |
| South | 5 |
| Saudi | 5 |
| ST | 5 |
| Supplement | 5 |
| Research | 5 |
| NFAT | 5 |
| ROC | 5 |
| Janus | 5 |
| Jian | 5 |
| London | 5 |
| L·min(−1 | 5 |
| James | 5 |
| Nationwide | 5 |
| Prevention | 5 |
| RCT | 5 |
| Interferon | 5 |
| Network | 5 |
| Dexamethasone | 4 |
| Diagnostic | 4 |
| Diseases | 4 |
| GINA | 4 |
| Du | 4 |
| ECFS | 4 |
| Editor | 4 |
| Elshof | 4 |
| Epidemiologic | 4 |
| Function | 4 |
| G. | 4 |
| Dr. | 4 |
| JNK | 4 |
| Gattinoni | 4 |
| General | 4 |
| Germany | 4 |
| Guideline | 4 |
| HCWs | 4 |
| HU | 4 |
| Hu | 4 |
| Hydroxychloroquine | 4 |
| IFNλ | 4 |
| Incidence | 4 |
| International | 4 |
| J. | 4 |
| DVT | 4 |
| David | 4 |
| CSF | 4 |
| DMSO | 4 |
| Belgium | 4 |
| Joint | 4 |
| AABIP | 4 |
| AEC | 4 |
| Adult | 4 |
| Adults | 4 |
| Andrea | 4 |
| Anti | 4 |
| Assessment | 4 |
| Attribution | 4 |
| BDG | 4 |
| BMI | 4 |
| Bompard | 4 |
| Ct | 4 |
| CK | 4 |
| CTN | 4 |
| Cardiovascular | 4 |
| Center | 4 |
| Cheng | 4 |
| Committee | 4 |
| Commons | 4 |
| Comorbidity | 4 |
| Corticosteroid | 4 |
| Creative | 4 |
| Critical | 4 |
| Jingzhou | 4 |
| Chalmers | 4 |
| Kinase | 4 |
| USA | 4 |
| Ventilator | 4 |
| Version | 4 |
| Wen | 4 |
| Wenzhou | 4 |
| Wu | 4 |
| Xiang | 4 |
| Xiangyang | 4 |
| Ⅲ | 4 |
| Zhao | 4 |
| Zheng | 4 |
| aerosol | 4 |
| baricitinib | 4 |
| bronchoalveolar | 4 |
| cyclophilin | 4 |
| doc_id | 4 |
| fu | 4 |
| kg | 4 |
| medRxiv | 4 |
| multicentre | 4 |
| m² | 4 |
| ng | 4 |
| tocilizumab | 4 |
| van | 4 |
| | | 4 |
| L. | 4 |
| V | 4 |
| hua | 4 |
| Tobacco | 4 |
| P13 | 4 |
| Lancet | 4 |
| Therapy | 4 |
| Licence | 4 |
| Lopinavir | 4 |
| Marc | 4 |
| Nan | 4 |
| Online | 4 |
| Oropharyngeal | 4 |
| Outcomes | 4 |
| P. | 4 |
| P06 | 4 |
| P11 | 4 |
| NHS | 4 |
| PPE | 4 |
| Ritonavir | 4 |
| Stefano | 4 |
| PPIase | 4 |
| Solidarity | 4 |
| SaO | 4 |
| Sichuan | 4 |
| Rapid | 4 |
| Pulmonology | 4 |
| Province | 4 |
| PS | 4 |
| Studies | 4 |
| Hainan | 3 |
| Guidance | 3 |
| Hai | 3 |
| HCW | 3 |
| H7N9 | 3 |
| Harbin | 3 |
| H. | 3 |
| H | 3 |
| Fifth | 3 |
| Guangdong | 3 |
| Guan | 3 |
| GAPDH | 3 |
| Fig | 3 |
| Feng | 3 |
| FcαRI | 3 |
| FEV1 | 3 |
| Hepatitis | 3 |
| FDA | 3 |
| Healthcare | 3 |
| Jin | 3 |
| Huang | 3 |
| Jiang | 3 |
| Estimation | 3 |
| LEUNG | 3 |
| Kong | 3 |
| K. | 3 |
| Jun | 3 |
| July | 3 |
| Jonathan | 3 |
| Jan | 3 |
| Hunan | 3 |
| Interim | 3 |
| Institute | 3 |
| Infections | 3 |
| India | 3 |
| Income | 3 |
| IL-6 | 3 |
| IL)-6 | 3 |
| Ethics | 3 |
| Baseline | 3 |
| Epidemiology | 3 |
| Approach | 3 |
| Carr | 3 |
| CS | 3 |
| Bicêtre | 3 |
| Berlin | 3 |
| Bench | 3 |
| Low | 3 |
| Australia | 3 |
| Application | 3 |
| Chemotherapy | 3 |
| Alisporivir | 3 |
| Alberto | 3 |
| Air | 3 |
| Accuracy | 3 |
| AUROCs | 3 |
| ANOVA | 3 |
| ADCC | 3 |
| Characterisation | 3 |
| Cherian | 3 |
| Effectiveness | 3 |
| Data | 3 |
| ERJ | 3 |
| EORTC | 3 |
| ECMO | 3 |
| E. | 3 |
| Dezhou | 3 |
| Decision | 3 |
| Database | 3 |
| Dalian | 3 |
| Chronic | 3 |
| Covid | 3 |
| Cov-2 | 3 |
| Coronaviruses | 3 |
| Community | 3 |
| Colleague | 3 |
| Cohort | 3 |
| Chun | 3 |
| Laura | 3 |
| Baricitinib | 3 |
| MAP | 3 |
| Resources | 3 |
| Testing | 3 |
| TKI | 3 |
| TGF | 3 |
| Systematic | 3 |
| Sweden | 3 |
| Survey | 3 |
| Sun | 3 |
| Strategies | 3 |
| Spirometry | 3 |
| Singapore | 3 |
| Shi | 3 |
| Shao | 3 |
| Shan | 3 |
| Severity | 3 |
| Seattle | 3 |
| S | 3 |
| Rome | 3 |
| Third | 3 |
| Toronto | 3 |
| Unit | 3 |
| eosinopenia | 3 |
| Marburg | 3 |
| subphenotypes | 3 |
| series | 3 |
| ruxolitinib | 3 |
| lymphopenia | 3 |
| hAEC | 3 |
| feng | 3 |
| bronchogram | 3 |
| Vannes | 3 |
| Yuan | 3 |
| Ye | 3 |
| Xu | 3 |
| Xavier | 3 |
| West | 3 |
| Week | 3 |
| Warning | 3 |
| Retrospective | 3 |
| Ventilation | 3 |
| Resmed | 3 |
| Neutrophil | 3 |
| PAI-1 | 3 |
| P= | 3 |
| P20 | 3 |
| Official | 3 |
| Observational | 3 |
| Nusair | 3 |
| Northern | 3 |
| Nava | 3 |
| Panel | 3 |
| NSCLC | 3 |
| Monitoring | 3 |
| Mission | 3 |
| Meta | 3 |
| Mei | 3 |
| Republic | 3 |
| Marco | 3 |
| PaO | 3 |
| North | 3 |
| Peng | 3 |
| Qiu | 3 |
| Remdesivir | 3 |
| Related | 3 |
| Physiology | 3 |
| Reactivation | 3 |
| Radiology | 3 |
| RUSSO | 3 |
| RA | 3 |
| R. | 3 |
| RR>20 | 3 |
| Protocol | 3 |
| Prospective | 3 |
| Predictors | 3 |
| Practice | 3 |
| Public | 3 |
| Positive | 3 |
| Platform | 3 |
| Guo | 2 |
| Handan | 2 |
| Glycoprotein | 2 |
| Haut | 2 |
| Hardware | 2 |
| HNFO | 2 |
| HRP | 2 |
| HCV | 2 |
| Hefei | 2 |
| Hebei | 2 |
| Huertas | 2 |
| Henan | 2 |
| High | 2 |
| Home | 2 |
| Host | 2 |
| Huaihua | 2 |
| Huangshi | 2 |
| Humbert | 2 |
| Hypoxaemia | 2 |
| Giessen | 2 |
| IFNL | 2 |
| Giuseppe | 2 |
| FFP3 | 2 |
| Geri | 2 |
| García | 2 |
| IPD | 2 |
| Etoposide | 2 |
| Expression | 2 |
| F12 | 2 |
| FCS | 2 |
| FN | 2 |
| Failure | 2 |
| Farsalinos | 2 |
| Fatal | 2 |
| FiO | 2 |
| Fink | 2 |
| Fleischner | 2 |
| Flow | 2 |
| Force | 2 |
| Frank | 2 |
| Frequency | 2 |
| Front | 2 |
| Fu | 2 |
| Fuyang | 2 |
| Fuzhou | 2 |
| GATTINONI | 2 |
| IL-10 | 2 |
| Lutchman | 2 |
| IgMbecame | 2 |
| Individual | 2 |
| Leung | 2 |
| Lianyungang | 2 |
| Liberation | 2 |
| Life | 2 |
| Line | 2 |
| Lonergan | 2 |
| Longitudinal | 2 |
| Louis | 2 |
| Lu | 2 |
| Luca | 2 |
| Luigi | 2 |
| Lumis | 2 |
| Epidemic | 2 |
| MCO | 2 |
| MIRACLE | 2 |
| MOI | 2 |
| MRC | 2 |
| MTB | 2 |
| Machine | 2 |
| Malaria | 2 |
| Manifestations | 2 |
| Lei | 2 |
| Laurent | 2 |
| Lan | 2 |
| JAKi | 2 |
| Inhibition | 2 |
| Inhibitors | 2 |
| Institutional | 2 |
| Intelligence | 2 |
| Intelligent | 2 |
| Intermediate | 2 |
| Interventional | 2 |
| Invasive | 2 |
| JAK1/2 | 2 |
| Janice | 2 |
| Lactoferrin | 2 |
| Ji | 2 |
| JinYinTan | 2 |
| Jing | 2 |
| K.D. | 2 |
| Kai | 2 |
| Kingdom | 2 |
| Klok | 2 |
| LABA | 2 |
| Laboratories | 2 |
| Epidemiological | 2 |
| ClinicalTrials.gov | 2 |
| Enrico | 2 |
| Campaign | 2 |
| Autonomous | 2 |
| BRC | 2 |
| BTS | 2 |
| BW | 2 |
| Barisione | 2 |
| Becker | 2 |
| Bei | 2 |
| Beijing | 2 |
| Belliato | 2 |
| Bi | 2 |
| Bo | 2 |
| Boruta | 2 |
| Breathing | 2 |
| Bronchology | 2 |
| Burden | 2 |
| CAP | 2 |
| CE | 2 |
| CITL | 2 |
| COV-2 | 2 |
| COVID- | 2 |
| COVID-2019 | 2 |
| Automatic | 2 |
| Aspergillus | 2 |
| Artificial | 2 |
| Agusti | 2 |
| Mario | 2 |
| -910 | 2 |
| -Preliminary | 2 |
| -case | 2 |
| 5L | 2 |
| AAK1 | 2 |
| ACE | 2 |
| Admission | 2 |
| Advanced | 2 |
| Alert | 2 |
| Army | 2 |
| Alexander | 2 |
| Allergy | 2 |
| Alvar | 2 |
| Anaesthetists | 2 |
| Antithrombotic | 2 |
| Anyang | 2 |
| Arduino | 2 |
| Area | 2 |
| Arjun | 2 |
| Calcineurin | 2 |
| Canada | 2 |
| England | 2 |
| Caramelo | 2 |
| Dear | 2 |
| Definition | 2 |
| Delta | 2 |
| Dengzhou | 2 |
| Department | 2 |
| Design | 2 |
| Devices | 2 |
| Don | 2 |
| Dxy | 2 |
| E1 | 2 |
| EC | 2 |
| EGFR | 2 |
| ELISA | 2 |
| ESC | 2 |
| ESCMID | 2 |
| Ebola | 2 |
| Effect | 2 |
| Emanuele | 2 |
| Emergency | 2 |
| Emerging | 2 |
| Emilia | 2 |
| De | 2 |
| Daniel | 2 |
| DST | 2 |
| Complications | 2 |
| Carlucci | 2 |
| Centers | 2 |
| Centre | 2 |
| Changde | 2 |
| Changping | 2 |
| Changsha | 2 |
| Charles | 2 |
| Chenzhou | 2 |
| Collection | 2 |
| Conseil | 2 |
| DMEM | 2 |
| Consensus | 2 |
| Consortium | 2 |
| Continuous | 2 |
| Correlation | 2 |
| Countries | 2 |
| Criteria | 2 |
| Critically | 2 |
| Cyclophilin | 2 |
| Cytotoxic | 2 |
| Mann | 2 |
| Airvo2 | 2 |
| Massachusetts | 2 |
| ergo | 2 |
| White | 2 |
| Whitney | 2 |
| Xi | 2 |
| Xpert | 2 |
| Yong | 2 |
| Yuhang | 2 |
| Zhan | 2 |
| Zhejiang | 2 |
| Zhongshan | 2 |
| Zhou | 2 |
| air | 2 |
| angiopathy | 2 |
| antiphospholipid | 2 |
| area(s | 2 |
| betaglycan | 2 |
| bronchoscopic | 2 |
| chen | 2 |
| committee | 2 |
| covid-19 | 2 |
| disease | 2 |
| durvalumab | 2 |
| Washington | 2 |
| Vitro | 2 |
| Vitoria | 2 |
| Tianjin | 2 |
| TA | 2 |
| TM | 2 |
| TMPRSS2 | 2 |
| Tang | 2 |
| Task | 2 |
| Technology | 2 |
| Thromboembolic | 2 |
| Thrombosis | 2 |
| Tian | 2 |
| Time | 2 |
| Ventilators | 2 |
| Tony | 2 |
| Transmission | 2 |
| Trials | 2 |
| U | 2 |
| VPAP | 2 |
| Vaccine | 2 |
| Validation | 2 |
| Value | 2 |
| Van | 2 |
| enzyme-2 | 2 |
| etoposide | 2 |
| Systems | 2 |
| formoterol | 2 |
| scan | 2 |
| sheng | 2 |
| siRNA | 2 |
| thromboprophylaxis | 2 |
| tofacitinib | 2 |
| vinorelbine | 2 |
| ward | 2 |
| 2 | |
| yan | 2 |
| yang | 2 |
| yi | 2 |
| yue | 2 |
| µg | 2 |
| β | 2 |
| β1b | 2 |
| χ2 | 2 |
| Ⅱ | 2 |
| ≤ | 2 |
| ≤37 | 2 |
| ≥2 | 2 |
| Matteo | 2 |
| qing | 2 |
| pyroptosis | 2 |
| proctor | 2 |
| lymphocytopenia | 2 |
| galactomannan | 2 |
| gemcitabine | 2 |
| hoc | 2 |
| hong | 2 |
| jie | 2 |
| jun | 2 |
| lactoferrin | 2 |
| lopinavir | 2 |
| lung | 2 |
| microangiopathy | 2 |
| perivascular | 2 |
| mid | 2 |
| ming | 2 |
| nares | 2 |
| nivo | 2 |
| nomogram | 2 |
| omalizumab | 2 |
| p=1.000 | 2 |
| pembrolizumab | 2 |
| pemetrexed | 2 |
| T | 2 |
| hydroxychloroquine | 2 |
| System | 2 |
| RIF | 2 |
| PTB | 2 |
| Paola | 2 |
| Paolo | 2 |
| Paykel | 2 |
| Pediatric | 2 |
| Pei | 2 |
| Perlman | 2 |
| Philipps | 2 |
| Pierre | 2 |
| Pietro | 2 |
| Predicting | 2 |
| Preliminary | 2 |
| Prognosis | 2 |
| Prognostic | 2 |
| Progression | 2 |
| Protective | 2 |
| Protein | 2 |
| Qi | 2 |
| Qiang | 2 |
| Qu | 2 |
| RALE | 2 |
| PBSdef | 2 |
| P19 | 2 |
| P05 | 2 |
| NAK | 2 |
| McAlinden | 2 |
| Suspected | 2 |
| Meier | 2 |
| Mitigation | 2 |
| Modeling | 2 |
| Mouse | 2 |
| Multicenter | 2 |
| Mycobacterium | 2 |
| Mycosis | 2 |
| NIHR | 2 |
| P02 | 2 |
| NOx | 2 |
| Nair | 2 |
| Nano | 2 |
| Nasal | 2 |
| Netherlands | 2 |
| Nuo | 2 |
| OneStep | 2 |
| Open | 2 |
| Ou | 2 |
| REMS | 2 |
| P18 | 2 |
| RS | 2 |
| Service | 2 |
| Signaling | 2 |
| Simon | 2 |
| Simone | 2 |
| Sixth | 2 |
| Sleep | 2 |
| Societies | 2 |
| Sotgiu | 2 |
| SpO2 | 2 |
| Spearman | 2 |
| Specimen | 2 |
| Specimens | 2 |
| Spike | 2 |
| Statement | 2 |
| Stephan | 2 |
| Storti | 2 |
| Strasbourg | 2 |
| Supplementary_Methods&Results.pdf | 2 |
| Radiographic | 2 |
| Support | 2 |
| Surviving | 2 |
| Suppression | 2 |
| Shah | 2 |
| Silke | 2 |
| Serrano | 2 |
| SD | 2 |
| Rajendram | 2 |
| Randomized | 2 |
| Recombinant | 2 |
| Rello | 2 |
| Reporting | 2 |
| Rheumatoid | 2 |
| Richard | 2 |
| Royal | 2 |
| S. | 2 |
| SABA | 2 |
| Roberto | 2 |
| SEM | 2 |
| Saclay | 2 |
| Safety | 2 |
| Salton | 2 |
| Santé | 2 |
| Series | 2 |
| SDS | 2 |
| Sepsis | 2 |
| Scheme | 2 |
| HG3 | 1 |
| Halling | 1 |
| Hakonarson | 1 |
| Hakon | 1 |
| Haikou | 1 |
| HIN1(09 | 1 |
| Haihe | 1 |
| HRCT | 1 |
| HIFs | 1 |
| HBV | 1 |
| HCSP | 1 |
| Halilaj | 1 |
| Hazard | 1 |
| Hamann | 1 |
| Hamilton | 1 |
| Han | 1 |
| Hanjiang | 1 |
| Hanshan | 1 |
| Hao | 1 |
| Hare | 1 |
| Harris | 1 |
| Harrois | 1 |
| Haudebourg | 1 |
| H1N1v | 1 |
| He | 1 |
| Heart | 1 |
| HBEpC | 1 |
| Granulocyte | 1 |
| H1N1(09 | 1 |
| Guang | 1 |
| Gongcheng | 1 |
| Hechi | 1 |
| Gongyi | 1 |
| 1 | |
| Gori | 1 |
| Gozal | 1 |
| Graham | 1 |
| Great | 1 |
| Greta | 1 |
| Gruber | 1 |
| Gu | 1 |
| Guang'an | 1 |
| Guy | 1 |
| Guangshan | 1 |
| Guangyao | 1 |
| Guaraldi | 1 |
| Guardian | 1 |
| Guglielmetti | 1 |
| Guidelli | 1 |
| Guiding | 1 |
| Guiot | 1 |
| Guoyao | 1 |
| Gupta | 1 |
| Gushi | 1 |
| Heath | 1 |
| Hyam | 1 |
| Hechuan | 1 |
| Hounsfield | 1 |
| Huai'an | 1 |
| Huaibei | 1 |
| Huainan | 1 |
| Huangchuan | 1 |
| Huangshan | 1 |
| Huazhong | 1 |
| Huichang | 1 |
| Huining | 1 |
| Huizhou | 1 |
| Huludao | 1 |
| Hulunbuir | 1 |
| Humanitarian | 1 |
| Humans | 1 |
| Humayra | 1 |
| Humoral | 1 |
| Hvidovre | 1 |
| Hypercoagulability | 1 |
| Hypoxemia | 1 |
| IB | 1 |
| ICNARC | 1 |
| ICNARC(11 | 1 |
| IFNλ1 | 1 |
| IFNλ3 | 1 |
| III- | 1 |
| Goesmann | 1 |
| Hua | 1 |
| Houben | 1 |
| Heederik | 1 |
| Hospitals | 1 |
| Hefeng | 1 |
| Heilongjiang | 1 |
| Hejin | 1 |
| Helsing | 1 |
| Hemostasis | 1 |
| Henchi | 1 |
| Heng | 1 |
| Henry | 1 |
| Hermann | 1 |
| Herold | 1 |
| Hexi | 1 |
| Heyuan | 1 |
| Heze | 1 |
| Hilty | 1 |
| Histopathological | 1 |
| Histopathology | 1 |
| Hofmann | 1 |
| Hohhot | 1 |
| Holistic | 1 |
| Honghe | 1 |
| Hoppe | 1 |
| Hormonal | 1 |
| Hosmer | 1 |
| Hospitalised | 1 |
| Hospitalization | 1 |
| Goletti | 1 |
| Essential | 1 |
| Goat | 1 |
| Filippo | 1 |
| Fabiano | 1 |
| Fabrizio | 1 |
| Facciolongo | 1 |
| Facing | 1 |
| Factor | 1 |
| Factory | 1 |
| Faculty | 1 |
| Fair | 1 |
| Fang | 1 |
| Farré | 1 |
| Fatality | 1 |
| Favaro | 1 |
| Faverio | 1 |
| Fc | 1 |
| Feasibility | 1 |
| Feature | 1 |
| Feb | 1 |
| Federated | 1 |
| Federica | 1 |
| Federici | 1 |
| Fengjie | 1 |
| Fergus | 1 |
| Fibrosis | 1 |
| Fig1 | 1 |
| Figure1D | 1 |
| FRI | 1 |
| FLORALI | 1 |
| FK | 1 |
| Epicenter | 1 |
| Emily | 1 |
| Emirates | 1 |
| Emphysema | 1 |
| Endemic | 1 |
| Endobronchial | 1 |
| Endothelialitis | 1 |
| Energy | 1 |
| Envelope | 1 |
| Environ | 1 |
| Eosinopenia | 1 |
| Epicardial | 1 |
| Equations | 1 |
| F | 1 |
| Er | 1 |
| Erik | 1 |
| Ermanno | 1 |
| IL | 1 |
| Etienne | 1 |
| Events | 1 |
| Evolution | 1 |
| Examination | 1 |
| Exchange | 1 |
| Experimental | 1 |
| Exposure | 1 |
| Figure1a | 1 |
| Finn | 1 |
| Goal | 1 |
| Fiona | 1 |
| Garner | 1 |
| Gas | 1 |
| Gasparini | 1 |
| Gattenloehner | 1 |
| Ge | 1 |
| Gel | 1 |
| Gen. | 1 |
| Genes | 1 |
| Genome | 1 |
| Gentile | 1 |
| Geoff | 1 |
| Georgia | 1 |
| Gerry | 1 |
| Giacomo | 1 |
| Giaunluigi | 1 |
| Giles | 1 |
| Gioachino | 1 |
| Giorgino | 1 |
| Giovanna | 1 |
| Girolami | 1 |
| Giulia | 1 |
| Giuliani | 1 |
| GlaxoSmithKline | 1 |
| Gleeson | 1 |
| Gloassay | 1 |
| Garmendia | 1 |
| Garfield | 1 |
| Gaolan | 1 |
| Françoise | 1 |
| Fitness | 1 |
| Florence | 1 |
| FluCAN | 1 |
| Fluid | 1 |
| Fluoprep | 1 |
| Formation | 1 |
| Foshan | 1 |
| Framework | 1 |
| Francesca | 1 |
| Franco | 1 |
| François | 1 |
| French | 1 |
| Ganzhou | 1 |
| Frix | 1 |
| Funder | 1 |
| Funding | 1 |
| Furong | 1 |
| G2A | 1 |
| G73/2017 | 1 |
| GADPH | 1 |
| GSK | 1 |
| GTN | 1 |
| Galactomannan | 1 |
| Gang | 1 |
| IIIb | 1 |
| Jordi | 1 |
| IL-1Ra | 1 |
| Lars | 1 |
| Lateral | 1 |
| Latin | 1 |
| Law | 1 |
| Lazaro | 1 |
| Learning | 1 |
| Lebeer | 1 |
| Lederlin | 1 |
| Leica | 1 |
| Lemeshow | 1 |
| Lengshuijiang | 1 |
| Leping | 1 |
| Leshan | 1 |
| Level | 1 |
| Levi | 1 |
| Lewis | 1 |
| Lianjiang | 1 |
| Liaocheng | 1 |
| Liaoning | 1 |
| Liberty | 1 |
| Lidwien | 1 |
| Lieuwe | 1 |
| Lieven | 1 |
| Lijiang | 1 |
| Lin | 1 |
| Lin'an | 1 |
| Lastoria | 1 |
| Larissa | 1 |
| Lineau | 1 |
| Lara | 1 |
| Kenneth | 1 |
| Keong | 1 |
| Khurana | 1 |
| Kirby | 1 |
| Kolmogorov | 1 |
| Koningsbruggen | 1 |
| Kotsimbos | 1 |
| Kruskal | 1 |
| Kunming | 1 |
| Kupferschmidt | 1 |
| Kupke | 1 |
| L1 | 1 |
| LLHBCH2020LW-006 | 1 |
| LMIC | 1 |
| LUKS | 1 |
| Lab | 1 |
| LabCorp | 1 |
| Laboratory | 1 |
| Lai | 1 |
| Laifeng | 1 |
| Laixi | 1 |
| Lambin | 1 |
| Lancang | 1 |
| Langelot | 1 |
| Lanzhou | 1 |
| Lina | 1 |
| Ling | 1 |
| IL-5 | 1 |
| M52010-WH | 1 |
| MAS1 | 1 |
| MC-19 | 1 |
| MCP)-1 | 1 |
| MDI | 1 |
| MDR | 1 |
| MEWS | 1 |
| MKK6-p38 | 1 |
| MKK7 | 1 |
| ML | 1 |
| MM13 | 1 |
| MONTEIL | 1 |
| MRI | 1 |
| MV | 1 |
| Ma | 1 |
| Maarten | 1 |
| Mahdad | 1 |
| Malawi | 1 |
| Malcolm | 1 |
| Malerba | 1 |
| Mammography | 1 |
| Managing | 1 |
| Manzhouli | 1 |
| Mao | 1 |
| Mar | 1 |
| Marcel | 1 |
| MAPK | 1 |
| M | 1 |
| Lingwei | 1 |
| Lymphocyte | 1 |
| Linqu | 1 |
| Linshui | 1 |
| Lipman | 1 |
| Lisa | 1 |
| List | 1 |
| Liver | 1 |
| Lixian | 1 |
| Lixin | 1 |
| Loading | 1 |
| Lobar | 1 |
| Lodigiani | 1 |
| Logistics | 1 |
| Longnan | 1 |
| Longshan | 1 |
| Lorenza | 1 |
| Lorenzo | 1 |
| Louisville | 1 |
| Lovinfosse | 1 |
| Ltd | 1 |
| Lu'an | 1 |
| Luciano | 1 |
| Lucie | 1 |
| Ludger | 1 |
| Luintel | 1 |
| Luo | 1 |
| Kefang | 1 |
| Kappa= | 1 |
| Kaplan | 1 |
| Imported | 1 |
| Imputation | 1 |
| Inc. | 1 |
| Incubation | 1 |
| Index | 1 |
| Indra | 1 |
| Induced | 1 |
| Industry | 1 |
| Inequalities | 1 |
| Influences | 1 |
| Informatics | 1 |
| Information | 1 |
| Ingelheim | 1 |
| Inhaled | 1 |
| Initiative | 1 |
| Inspiratory | 1 |
| IntechOpen | 1 |
| Integrity | 1 |
| Interaction | 1 |
| Interleukin-2 | 1 |
| Intersurgical | 1 |
| Interview | 1 |
| Intracellular | 1 |
| Investigation | 1 |
| Invitrogen | 1 |
| Involve | 1 |
| Improvement | 1 |
| Implication | 1 |
| KOLMI | 1 |
| Imperial | 1 |
| IL-8 | 1 |
| IMT | 1 |
| INHASCO | 1 |
| IOQS | 1 |
| IQR25 | 1 |
| IRF1-IFNλ | 1 |
| IRF1-expressing | 1 |
| IRF3 | 1 |
| IRF7 | 1 |
| IRF9 | 1 |
| IRFs | 1 |
| ISGs | 1 |
| ISRCTN50189673 | 1 |
| IT | 1 |
| Iain | 1 |
| Ibrahim | 1 |
| Identification | 1 |
| IgG2b | 1 |
| Ilaria | 1 |
| Ile | 1 |
| Illness | 1 |
| Image | 1 |
| Imbalanced | 1 |
| Immune | 1 |
| Immunol | 1 |
| Iran | 1 |
| Isabel | 1 |
| Isolation | 1 |
| Israel | 1 |
| Jiulongpo | 1 |
| Jixi | 1 |
| Jo | 1 |
| Johanna | 1 |
| John | 1 |
| Johnson | 1 |
| Johnstone | 1 |
| Embolism | 1 |
| Jorge | 1 |
| Josep | 1 |
| Joseph | 1 |
| Joshi | 1 |
| Josuel | 1 |
| José | 1 |
| Jouneau | 1 |
| Judith | 1 |
| Julia | 1 |
| Julien | 1 |
| June | 1 |
| Justin | 1 |
| Jutant | 1 |
| Jérémie | 1 |
| Jérémy | 1 |
| KCO | 1 |
| KILLERBY | 1 |
| Jinzhong | 1 |
| Jining | 1 |
| Jinhua | 1 |
| Jaïs | 1 |
| Italian | 1 |
| Iva | 1 |
| J.J. | 1 |
| J.M. | 1 |
| JBF | 1 |
| JL | 1 |
| Jacob | 1 |
| Jacques | 1 |
| Janssens | 1 |
| Japan | 1 |
| Jarmer | 1 |
| Jean | 1 |
| Jingjiang | 1 |
| Jefferson | 1 |
| Jevnikar | 1 |
| Jia | 1 |
| Jiangyou | 1 |
| Jianlin | 1 |
| Jianping | 1 |
| Jiashan | 1 |
| Jiawei | 1 |
| Jieyang | 1 |
| Jilin | 1 |
| Jinan | 1 |
| Emergence | 1 |
| Dandan | 1 |
| Embase | 1 |
| BACKGROUND | 1 |
| BNP | 1 |
| BOLUO | 1 |
| BSL-4 | 1 |
| BSL4 | 1 |
| Babol | 1 |
| Badong | 1 |
| Baillie | 1 |
| Baise | 1 |
| Bao | 1 |
| Baoding | 1 |
| Baptiste | 1 |
| Barrier | 1 |
| Bartenschlager | 1 |
| Barthélemy | 1 |
| Based | 1 |
| Battista | 1 |
| Bayannur | 1 |
| Bb | 1 |
| Beatrice | 1 |
| Belgian | 1 |
| Bellin | 1 |
| Ben | 1 |
| Bengbu | 1 |
| Berka | 1 |
| Bertolli | 1 |
| BALT | 1 |
| B. | 1 |
| Antigenicity | 1 |
| Azole | 1 |
| Antoine | 1 |
| Anxi | 1 |
| Anyuan | 1 |
| Apnea | 1 |
| Applicability | 1 |
| Arab | 1 |
| Arcaro | 1 |
| Arginine | 1 |
| Armed | 1 |
| Armstrong | 1 |
| Arnouat | 1 |
| Arxiv | 1 |
| Asian | 1 |
| Aspergillusspecific | 1 |
| AspiFlu | 1 |
| Assays | 1 |
| Assoc | 1 |
| AstraZeneca | 1 |
| Asynchrony | 1 |
| Athénaïs | 1 |
| Atlanta | 1 |
| Audrey | 1 |
| Auray | 1 |
| Automation | 1 |
| Azithromycin | 1 |
| Beta | 1 |
| Beurnier | 1 |
| Beyond | 1 |
| Bias | 1 |
| Broad | 1 |
| Bronchoscopic | 1 |
| Bronchoscopies | 1 |
| Bronchus | 1 |
| Brown | 1 |
| Brugger | 1 |
| Bryan | 1 |
| Buchan | 1 |
| Bulifon | 1 |
| Bulteel | 1 |
| Bureau | 1 |
| Business | 1 |
| C.H. | 1 |
| C.L. | 1 |
| C57BL/6 | 1 |
| CALL | 1 |
| CARDS | 1 |
| CC | 1 |
| CCC19 | 1 |
| CCP | 1 |
| CD147 | 1 |
| CD89 | 1 |
| CFSensor | 1 |
| CI+ | 1 |
| CIP | 1 |
| Brittany | 1 |
| Brilliance | 1 |
| Brijesh | 1 |
| Blackwood | 1 |
| Bicanic | 1 |
| Bilevel | 1 |
| Bin | 1 |
| Bing | 1 |
| Bio | 1 |
| Bioaerosols | 1 |
| Biomedical | 1 |
| Biomérieux | 1 |
| Biotechnology | 1 |
| Biruta | 1 |
| Bizec | 1 |
| Blanc | 1 |
| Bram | 1 |
| Blockade | 1 |
| Bloomfield | 1 |
| Boards | 1 |
| Bodies | 1 |
| Boehringer | 1 |
| Bonaduz | 1 |
| Bondt | 1 |
| Bonifazi | 1 |
| Borisov | 1 |
| Boucly | 1 |
| Bouzat | 1 |
| Antiviral | 1 |
| Antibody | 1 |
| CMTEG | 1 |
| 18,P20 | 1 |
| 3(4 | 1 |
| 3.5.3 | 1 |
| 40mg | 1 |
| 6e908aaa401debce86d240e6228b1c760cd59240 | 1 |
| 816034c362e494e9f9737a0b8c3090909beabf7e | 1 |
| 921st | 1 |
| A. | 1 |
| A.M. | 1 |
| ACEi | 1 |
| ACKERMANN | 1 |
| ACP | 1 |
| ACTT-1 | 1 |
| ADASYN | 1 |
| ADEM)-like | 1 |
| ADOC | 1 |
| AGP | 1 |
| AIDS | 1 |
| AIM | 1 |
| ANZICS | 1 |
| ARF | 1 |
| AT | 1 |
| AUC=0.5 | 1 |
| AVPU | 1 |
| Abdolrasouli | 1 |
| Abubakar | 1 |
| 252/411 | 1 |
| 10L | 1 |
| Anthony | 1 |
| 10.1183/13993003.02672 | 1 |
| Maria | 1 |
| -2 | 1 |
| -2019 | 1 |
| -6 | 1 |
| -856 | 1 |
| -9 | 1 |
| -A | 1 |
| -COVID-19 | 1 |
| -Case | 1 |
| -Ethics | 1 |
| -Georgia | 1 |
| -Nottingham | 1 |
| -United | 1 |
| -drug | 1 |
| -guidelines | 1 |
| /100 | 1 |
| 0.73–0.83 | 1 |
| 0/38 | 1 |
| 1,3-beta | 1 |
| 1.07–2.32 | 1 |
| 10.1183/13993003.00697 | 1 |
| 10.1183/13993003.01112 | 1 |
| 10.1183/13993003.01759 | 1 |
| 10.1183/13993003.01809 | 1 |
| 10.1183/13993003.02328 | 1 |
| Academy | 1 |
| Access | 1 |
| Accurate | 1 |
| Acheng | 1 |
| Am | 1 |
| Amazon | 1 |
| Ambient | 1 |
| Amedeo | 1 |
| Anakinra | 1 |
| Analytics | 1 |
| Anand | 1 |
| Anatole | 1 |
| Andrei | 1 |
| Angelo | 1 |
| Angio | 1 |
| Angiogenesis | 1 |
| Angiography | 1 |
| Angiotensin | 1 |
| Anguo | 1 |
| Anh | 1 |
| Anhui | 1 |
| Ankang | 1 |
| Ankara | 1 |
| Anlong | 1 |
| Annalisa | 1 |
| Anne | 1 |
| Annelies | 1 |
| Annemarie | 1 |
| Annette | 1 |
| Alyn | 1 |
| Almerico | 1 |
| Allocation | 1 |
| Aggarwal | 1 |
| Achim | 1 |
| Activation | 1 |
| Activator | 1 |
| Active | 1 |
| Adenovirus | 1 |
| Adjuvant | 1 |
| Administration | 1 |
| Advance | 1 |
| Aerosol | 1 |
| Aged | 1 |
| Agency | 1 |
| Agility | 1 |
| Alkesh | 1 |
| Aida | 1 |
| Akish | 1 |
| Alanio | 1 |
| Albarello | 1 |
| Aldrich | 1 |
| Alessandra | 1 |
| AlexaFluor | 1 |
| Alexandra | 1 |
| Alexandre | 1 |
| Alexandrina | 1 |
| Alireza | 1 |
| CL3 | 1 |
| COPE | 1 |
| Emanuela | 1 |
| Dazhou | 1 |
| DeLong | 1 |
| Dec | 1 |
| Decentralisation | 1 |
| Decisions | 1 |
| Declaration | 1 |
| Delayed | 1 |
| Delia | 1 |
| Demographic | 1 |
| Denning | 1 |
| Departments | 1 |
| Deqing | 1 |
| Desheng | 1 |
| Deterioration | 1 |
| Device | 1 |
| Di | 1 |
| Diabetes | 1 |
| Dianjiang | 1 |
| Dianova | 1 |
| Dick | 1 |
| Dickson | 1 |
| Dietzel | 1 |
| Dimar | 1 |
| Dimer | 1 |
| Ding | 1 |
| Dingqiao | 1 |
| Ddimer | 1 |
| Day | 1 |
| Cruz | 1 |
| Davì | 1 |
| Créac'hcadec | 1 |
| CsA. | 1 |
| Cushnan | 1 |
| Cyclophosphamide | 1 |
| Cystic | 1 |
| D'Abramo | 1 |
| D'Arcangelo | 1 |
| D(LCO)/V(A | 1 |
| D.J. | 1 |
| DAPI | 1 |
| DECT | 1 |
| DLCO | 1 |
| DNR | 1 |
| DPP4 | 1 |
| Dako | 1 |
| Dali | 1 |
| Damian | 1 |
| Dan | 1 |
| Danyang | 1 |
| Danzhou | 1 |
| Daocheng | 1 |
| Darius | 1 |
| Databases | 1 |
| Date | 1 |
| Datong | 1 |
| Dinh | 1 |
| Dipeptidyl | 1 |
| Directive | 1 |
| Director | 1 |
| E1505 | 1 |
| E2 | 1 |
| E3 | 1 |
| E6 | 1 |
| ECMM | 1 |
| EM | 1 |
| EMA | 1 |
| EMC | 1 |
| EMC/2012 | 1 |
| EPTB | 1 |
| ERS)The | 1 |
| ERS2 | 1 |
| ESMO | 1 |
| EWAS | 1 |
| Eastern | 1 |
| Economic | 1 |
| Edema | 1 |
| Edey | 1 |
| Edition | 1 |
| Effects | 1 |
| Efficacy | 1 |
| Ehrmann | 1 |
| Eighth | 1 |
| Elaboration | 1 |
| Elizabeth | 1 |
| E-10 | 1 |
| Dysfunction | 1 |
| Dynamics | 1 |
| Dongfeng | 1 |
| Dirk | 1 |
| Discovery | 1 |
| Disease-19 | 1 |
| Disesase | 1 |
| Dispersion | 1 |
| Distributed | 1 |
| Distribution | 1 |
| Docherty | 1 |
| Doctor | 1 |
| Dominic | 1 |
| Dong | 1 |
| Dongilli | 1 |
| Dutch | 1 |
| Dongqin | 1 |
| Dongsheng | 1 |
| Dongxiang | 1 |
| Downey | 1 |
| Dr | 1 |
| Dracula | 1 |
| Driven | 1 |
| Dual | 1 |
| Dunlevy | 1 |
| Dupont | 1 |
| Duranteau | 1 |
| Cryo | 1 |
| Cross | 1 |
| COPI | 1 |
| Causes | 1 |
| Cells | 1 |
| Centanni | 1 |
| Centered | 1 |
| Chadeau | 1 |
| Chai | 1 |
| Chained | 1 |
| Challenges | 1 |
| Chambers | 1 |
| Chang | 1 |
| Changes | 1 |
| Chaoyang | 1 |
| Characterization | 1 |
| Charlotte | 1 |
| Chaumais | 1 |
| CheckMate | 1 |
| Chenggong | 1 |
| Chengjiang | 1 |
| Chengkou | 1 |
| Chenxi | 1 |
| ChiCTR2000030861 | 1 |
| Chicago | 1 |
| Chiesi | 1 |
| Chiocchi | 1 |
| Chizhou | 1 |
| Chong | 1 |
| Cavalli | 1 |
| Catherine | 1 |
| Crisis | 1 |
| Cassandra | 1 |
| COV2 | 1 |
| COVID-19-specific | 1 |
| COVID-19specific | 1 |
| CPK | 1 |
| CURB65 | 1 |
| Cai | 1 |
| Caiyun | 1 |
| Calbiochem | 1 |
| Calcium | 1 |
| Calculator | 1 |
| Calibration | 1 |
| Calu3 | 1 |
| Calvin | 1 |
| Camille | 1 |
| Camporota | 1 |
| CanCOLD | 1 |
| Canadian | 1 |
| Cancers | 1 |
| Cannula | 1 |
| Capacity | 1 |
| Capital | 1 |
| Cardiology | 1 |
| Cardiothorac | 1 |
| Carlo | 1 |
| Caspase | 1 |
| Chongxin | 1 |
| Chongyi | 1 |
| Chowdhury | 1 |
| Christian | 1 |
| Comorbidities | 1 |
| Comparative | 1 |
| Compiègne | 1 |
| Complement | 1 |
| Confalonieri | 1 |
| Confirmation | 1 |
| Conflict | 1 |
| Consolidation | 1 |
| Contacts | 1 |
| Contagiousness | 1 |
| Conundrum | 1 |
| Corning | 1 |
| Corona | 1 |
| Coronarvirus | 1 |
| Coronary | 1 |
| Corsico | 1 |
| Corticosteroids | 1 |
| Cosimo | 1 |
| Course | 1 |
| Coverage | 1 |
| Coziana | 1 |
| Crac'h | 1 |
| Creil | 1 |
| Criel | 1 |
| Crises | 1 |
| Comorbid | 1 |
| Communicable | 1 |
| Common | 1 |
| CoV(-2 | 1 |
| Christin | 1 |
| Christine | 1 |
| Chunyan | 1 |
| Cinzia | 1 |
| Cipolla | 1 |
| Cisplatin | 1 |
| Ciurtin | 1 |
| Claire | 1 |
| Claudia | 1 |
| Clini | 1 |
| Close | 1 |
| CoV- | 1 |
| Comment | 1 |
| CoV-2-specific | 1 |
| CoV-2003 | 1 |
| CoVID-19 | 1 |
| Coagulopathy | 1 |
| Cochrane | 1 |
| Codecasa | 1 |
| Coils | 1 |
| Collaboration | 1 |
| Collaborative | 1 |
| Colm | 1 |
| Colombi | 1 |
| Marcello | 1 |
| Tabbi | 1 |
| Mariaelena | 1 |
| Xixian | 1 |
| Xuan | 1 |
| Xuanwu | 1 |
| Xue | 1 |
| Xuejiao | 1 |
| YX | 1 |
| Ya | 1 |
| Yajie | 1 |
| Yao | 1 |
| Year | 1 |
| Years | 1 |
| Yongchuan | 1 |
| Yongyi | 1 |
| Youngs | 1 |
| Youxian | 1 |
| Yuanliang | 1 |
| Yue | 1 |
| Yuehan | 1 |
| Yunnan | 1 |
| Yunyang | 1 |
| ZHANG | 1 |
| ZHOU | 1 |
| Zeng | 1 |
| Zhangye | 1 |
| Zhijiang | 1 |
| Zhoukou | 1 |
| Xiyuan | 1 |
| Xiong | 1 |
| Wilcoxon | 1 |
| Xinye | 1 |
| Withdrawal | 1 |
| Witte | 1 |
| Women | 1 |
| Wong | 1 |
| Woodruff | 1 |
| Working | 1 |
| Wort | 1 |
| Woznitza | 1 |
| WristOx | 1 |
| Wuhu | 1 |
| Wuxi | 1 |
| Wuyuan | 1 |
| Wuzhou | 1 |
| X | 1 |
| XGZP6847005KPG | 1 |
| Xeljanz | 1 |
| Xian | 1 |
| Xiangang | 1 |
| Xiansheng | 1 |
| Xiaoshan | 1 |
| Xie | 1 |
| 1 | |
| Xinjiang | 1 |
| Xinmi | 1 |
| Xinxiang | 1 |
| Zhoushan | 1 |
| Zhu | 1 |
| Zhumadian | 1 |
| Zhuzhou | 1 |
| bin | 1 |
| blind | 1 |
| budesonide/ | 1 |
| c40478d01d23bc18707d55e728067eeb97d0f4f6 | 1 |
| cadfb4b61d7d61f8dfacf62f53b6d48bc0d17f75 | 1 |
| calcineurin | 1 |
| cardiopathy | 1 |
| causal | 1 |
| celldependent | 1 |
| cells·μL | 1 |
| chemoattractant | 1 |
| chest | 1 |
| chloroquine | 1 |
| chong | 1 |
| cis | 1 |
| class | 1 |
| clofazimine | 1 |
| cmH | 1 |
| cmH(2)O | 1 |
| conotoxin | 1 |
| cord-259453 | 1 |
| cord-285897-ahysay2l | 1 |
| cord-290378-h4cof32 | 1 |
| cord-293691-ewerquin | 1 |
| cord-296440 | 1 |
| bevacizumab | 1 |
| betacoronaviruses | 1 |
| beta-1b | 1 |
| airflow | 1 |
| Zi | 1 |
| Zimmermann | 1 |
| Zuccatosta | 1 |
| Zucchi | 1 |
| ^Clinician | 1 |
| a541426b81026747429a0575ca5ca1c82be9a38c | 1 |
| a6cc74642a325ae482511f38a715b13b4702c17b | 1 |
| a95bfca76ef1104955ffeaa9953a6093c90a501f | 1 |
| aca25c980574d868b03dbb67c89bd4ea7c4758e6 | 1 |
| access | 1 |
| ahysay2l | 1 |
| alanine | 1 |
| bc4ab266ab0eb2d56cf2efc92c8205dd0a2d7cf6 | 1 |
| all'infezione | 1 |
| analysis | 1 |
| apnea | 1 |
| aspergillosis | 1 |
| assembly | 1 |
| association | 1 |
| asthma | 1 |
| atezolizumab | 1 |
| aziende | 1 |
| ba3e4c94f36f902a52a1550415c25308ea80b68d | 1 |
| bb2b1789e8eb50588b0f47dd85d4629104db2ce2 | 1 |
| Williams | 1 |
| Whole | 1 |
| cord-299679 | 1 |
| Times | 1 |
| Tiphaine | 1 |
| Tobias | 1 |
| Tocilizumab | 1 |
| Tom | 1 |
| Tomaselli | 1 |
| Tommy | 1 |
| Tomography | 1 |
| Tonelli | 1 |
| Tongchuan | 1 |
| Tongren | 1 |
| Tool | 1 |
| Tor | 1 |
| Torrego | 1 |
| Traditional | 1 |
| Transcription | 1 |
| Transgenic | 1 |
| Transparent | 1 |
| Treatments | 1 |
| Triage | 1 |
| Trigger | 1 |
| Triple | 1 |
| Triweekly | 1 |
| Trust | 1 |
| Tsiodras | 1 |
| Tuan | 1 |
| Tingting | 1 |
| Tillio | 1 |
| Wenzhi | 1 |
| Tihana | 1 |
| Switzerland | 1 |
| T. | 1 |
| TCID | 1 |
| TCID(50 | 1 |
| TER | 1 |
| TRIPOD | 1 |
| Tadolini | 1 |
| Taiwan | 1 |
| Tarantini | 1 |
| Tavares | 1 |
| Technical_Description.zip | 1 |
| Technologies | 1 |
| Temporal | 1 |
| Teniposide | 1 |
| Thermo | 1 |
| Thirtyone | 1 |
| Thomas | 1 |
| Thorsten | 1 |
| Thrombin | 1 |
| Thromboelastography | 1 |
| Thromboembolism | 1 |
| Thrombotic | 1 |
| Tiantai | 1 |
| Tiberi | 1 |
| Tidal | 1 |
| Tujia | 1 |
| UCLH | 1 |
| UK)(10 | 1 |
| UKRI | 1 |
| Vero | 1 |
| Verweij | 1 |
| Veterans | 1 |
| Vianello | 1 |
| Vigo | 1 |
| Villa | 1 |
| Vincenzo | 1 |
| Vinculin | 1 |
| ViraQuest | 1 |
| Viral | 1 |
| Virchow | 1 |
| Virol | 1 |
| Virology | 1 |
| Vivek | 1 |
| Volume | 1 |
| Vornhagen | 1 |
| W. | 1 |
| WANG | 1 |
| WISCO | 1 |
| Wai | 1 |
| Wallis | 1 |
| Wanzhou | 1 |
| Weihai | 1 |
| Wener | 1 |
| Wenwu | 1 |
| Vermeulen | 1 |
| Verma | 1 |
| Vergata | 1 |
| Utilization | 1 |
| ULCH | 1 |
| Ultrastructural | 1 |
| Underresourced | 1 |
| Union | 1 |
| Universal | 1 |
| Università | 1 |
| Up | 1 |
| Upper | 1 |
| Upregulated | 1 |
| Urban | 1 |
| Utility | 1 |
| V. | 1 |
| Venous | 1 |
| VA | 1 |
| VILI | 1 |
| Vaccination | 1 |
| Vaccinia | 1 |
| Vancouver | 1 |
| Varinder | 1 |
| Varun | 1 |
| Vascular | 1 |
| Vasta | 1 |
| Veerdonk | 1 |
| Veerle | 1 |
| cord-296694 | 1 |
| cord-322075-e6whegrf | 1 |
| Swine | 1 |
| r=-0.569 | 1 |
| radiomics | 1 |
| range | 1 |
| rehabilitation | 1 |
| relativi | 1 |
| remdisivir | 1 |
| review | 1 |
| ritonavir | 1 |
| rmda | 1 |
| rms | 1 |
| rog2h4g7 | 1 |
| rui | 1 |
| sIgA | 1 |
| sb7kgu24 | 1 |
| scientifici | 1 |
| sckfkciz | 1 |
| sd | 1 |
| sdstnm9i | 1 |
| segmentelevation | 1 |
| septa | 1 |
| seq | 1 |
| serology | 1 |
| serum | 1 |
| shenzhen | 1 |
| sign | 1 |
| srl | 1 |
| rRT | 1 |
| r=-0.432 | 1 |
| p=0.026 | 1 |
| quartilethird | 1 |
| p=0.100 | 1 |
| p=0.23 | 1 |
| p=0.381 | 1 |
| pandemic | 1 |
| pathogenfree | 1 |
| patient"s | 1 |
| peak | 1 |
| peking | 1 |
| peptidyl | 1 |
| phosphodiesterase-5 | 1 |
| ping | 1 |
| post | 1 |
| pred | 1 |
| prednisone | 1 |
| pretomanid | 1 |
| prise | 1 |
| prolyl | 1 |
| prophlyaxis | 1 |
| pulmonology | 1 |
| qPCR | 1 |
| qRT | 1 |
| qin | 1 |
| qiong | 1 |
| quan | 1 |
| quartile | 1 |
| sterni | 1 |
| sumer | 1 |
| swab(s | 1 |
| tPA | 1 |
| ypaevb8b | 1 |
| yu | 1 |
| z28bws23 | 1 |
| zhou | 1 |
| zhuo | 1 |
| © | 1 |
| ° | 1 |
| ±15 | 1 |
| ±4.1 | 1 |
| ±5.1 | 1 |
| µm | 1 |
| α7-nAChR | 1 |
| λ | 1 |
| μmol | 1 |
| ‡ | 1 |
| ≥ | 1 |
| ≥0.3 | 1 |
| ≥2.973 | 1 |
| ≥24h | 1 |
| ≥25 | 1 |
| ≥3 | 1 |
| ≥50 | 1 |
| ≥60 | 1 |
| ⩽75 | 1 |
| | 1 |
| yong | 1 |
| xiang | 1 |
| www.who.int | 1 |
| uCT | 1 |
| tele | 1 |
| test | 1 |
| tetratricopeptide | 1 |
| time | 1 |
| topotecan | 1 |
| trans | 1 |
| transcellular | 1 |
| transmembrane | 1 |
| transwell | 1 |
| triweekly | 1 |
| u3mkfvxw | 1 |
| un | 1 |
| www | 1 |
| university | 1 |
| use(9 | 1 |
| vdm55zvq | 1 |
| vera | 1 |
| vi | 1 |
| viii | 1 |
| vivo | 1 |
| wall | 1 |
| wei | 1 |
| wen | 1 |
| white | 1 |
| p=0.054 | 1 |
| p=0.01 | 1 |
| cord-322580 | 1 |
| ef4c0ad1310ec0aa74526d9109f06db55cd87a97 | 1 |
| endotypes | 1 |
| enquête | 1 |
| eosinopenic | 1 |
| ethambutol | 1 |
| ewerquin | 1 |
| ex | 1 |
| f3af29a29ff1b774f75206250b7b8eadf7925704 | 1 |
| f483d6b3c3ee441bd180f37a5815935881301fee | 1 |
| f67f7f850fe4abfbbb13ac87abcaaf2b1710d499 | 1 |
| facepiece | 1 |
| fibrinolysis | 1 |
| flj352ql | 1 |
| fumarate | 1 |
| g. | 1 |
| general | 1 |
| groups(10 | 1 |
| h4cof32 | 1 |
| hDPP4-mCherry | 1 |
| hematoxylin | 1 |
| heparin | 1 |
| highflow | 1 |
| house | 1 |
| https://bit.ly/ | 1 |
| https://bit.ly/2YL2eaK | 1 |
| https://bit.ly/36k2O2Q | 1 |
| elastance | 1 |
| echocardiographic | 1 |
| p=0.0026 | 1 |
| east | 1 |
| cord-335198-qp964238 | 1 |
| cord-337889 | 1 |
| cord-339934-g6ufz29l | 1 |
| cord-351407 | 1 |
| coronavirus-2 | 1 |
| coronaviruses | 1 |
| coronovirus | 1 |
| corticosteroid | 1 |
| coverslipped | 1 |
| cun | 1 |
| cyclophilins | 1 |
| cyclosporine | 1 |
| d'Anjou | 1 |
| d024ad990b81f2ecf2ca1a3a0192ef66ddb5515b | 1 |
| d123689685dc1c5735e0cb8fce7af0dc4c01bb65 | 1 |
| d2a5b9fc0234ce6c09dfc525b59f14268659db45 | 1 |
| d8b9887dc89d5f2e2a1d89d837d06c21429eced5 | 1 |
| da | 1 |
| data | 1 |
| dehydrogenas | 1 |
| dexamethasone | 1 |
| diesease | 1 |
| e0cf98a657713104ae23249d55752070787cc092 | 1 |
| e20415c2674a7bde2a993aa003c77a183736227e | 1 |
| e6whegrf | 1 |
| https://bit.ly/37dSB8l | 1 |
| hvx5m2bx | 1 |
| hypercapnic | 1 |
| hyperinflammatory | 1 |
| metereddose | 1 |
| methyllycaconitine | 1 |
| micro | 1 |
| middle | 1 |
| middleincome | 1 |
| mm | 1 |
| monocyte | 1 |
| muefay2n | 1 |
| multiorgan | 1 |
| myelofibrosis | 1 |
| n=5 | 1 |
| naso | 1 |
| national | 1 |
| nd | 1 |
| ng·L | 1 |
| ng·mL | 1 |
| nipah | 1 |
| nivolumab | 1 |
| noncardiac | 1 |
| noncontrast | 1 |
| nonsurge | 1 |
| oa2012410 | 1 |
| openlabel | 1 |
| orange | 1 |
| ospedaliere | 1 |
| mean±SE | 1 |
| manubrium | 1 |
| mRNA | 1 |
| jiang | 1 |
| hypocapnia | 1 |
| hypoinflammatory | 1 |
| icumen | 1 |
| inhospital | 1 |
| institutional | 1 |
| interferon | 1 |
| interleukin-6 | 1 |
| interlobular | 1 |
| intrapartum | 1 |
| isotypes | 1 |
| jian | 1 |
| jxigsdzh | 1 |
| mLand | 1 |
| kinase | 1 |
| l'adulte | 1 |
| li | 1 |
| liang | 1 |
| lin | 1 |
| linezolid | 1 |
| ling | 1 |
| loxe11d6 | 1 |
| lymphohistiocytosis | 1 |
| m2 | 1 |
| mL | 1 |
| Swiss | 1 |
| Susanne | 1 |
| Mariana | 1 |
| Openshaw | 1 |
| Ora | 1 |
| Oranger | 1 |
| Organ | 1 |
| Organisation | 1 |
| Otero | 1 |
| Other | 1 |
| Ottavia | 1 |
| Out | 1 |
| Outbreak | 1 |
| Overdiagnosis | 1 |
| Oxford | 1 |
| P01 | 1 |
| P04 | 1 |
| P08 | 1 |
| P10 | 1 |
| P17 | 1 |
| PA | 1 |
| PAI | 1 |
| PAR | 1 |
| PAR-1 | 1 |
| PBS | 1 |
| PD | 1 |
| PD-1 | 1 |
| PETERS | 1 |
| PFA | 1 |
| Opportunities | 1 |
| Onintza | 1 |
| Niikura | 1 |
| Oncology | 1 |
| Ning | 1 |
| Nist | 1 |
| Noelle | 1 |
| Nomogram | 1 |
| Nomograms | 1 |
| None | 1 |
| Nonhuman | 1 |
| Nonin | 1 |
| Noninvasive | 1 |
| Nonsquamous | 1 |
| Nonstructural | 1 |
| Nonsurgical | 1 |
| Noursadeghi | 1 |
| Novartis | 1 |
| November | 1 |
| Nowcasting | 1 |
| Noël | 1 |
| NuvoAir | 1 |
| O. | 1 |
| O2 | 1 |
| OPTIMAM | 1 |
| Obesity | 1 |
| Observations | 1 |
| Occhipinti | 1 |
| Olivier | 1 |
| PM2.5 | 1 |
| PPI | 1 |
| PPV | 1 |
| PROBAST | 1 |
| Pesci | 1 |
| Peter | 1 |
| Peteranderl | 1 |
| Phan | 1 |
| Pharmacology | 1 |
| Phase | 1 |
| Philippe | 1 |
| Philips | 1 |
| Phuong | 1 |
| Physicians | 1 |
| Pichon | 1 |
| Pierpaolo | 1 |
| Ping | 1 |
| Pingyao | 1 |
| Pisani | 1 |
| Plasminogen | 1 |
| Platinum/ | 1 |
| Plus | 1 |
| Plymouth | 1 |
| Point | 1 |
| Policy | 1 |
| Pollution | 1 |
| Population | 1 |
| Post | 1 |
| Postmortem | 1 |
| Personal | 1 |
| Period | 1 |
| Pemetrexed | 1 |
| Pasini | 1 |
| PUIs | 1 |
| PY | 1 |
| PaO(2)/FiO(2 | 1 |
| Page | 1 |
| Pagliuca | 1 |
| Pallav | 1 |
| Papa | 1 |
| Parent | 1 |
| Parker | 1 |
| Parravicini | 1 |
| Participant | 1 |
| Patel | 1 |
| Pellegrino | 1 |
| Pathogenesis | 1 |
| Pathogenic | 1 |
| Pathology | 1 |
| Pathway | 1 |
| Patrizia | 1 |
| Pattern | 1 |
| Patterns | 1 |
| Paul | 1 |
| Peak | 1 |
| Pearson | 1 |
| Peking | 1 |
| Nina | 1 |
| Nightingale | 1 |
| Practical | 1 |
| Mechanics | 1 |
| MedRxiv | 1 |
| Median | 1 |
| Medolla | 1 |
| Meerbeeck | 1 |
| Mehra | 1 |
| Mehta | 1 |
| Mellitus | 1 |
| Members | 1 |
| Memorial | 1 |
| Mexico | 1 |
| Mianyang | 1 |
| Mice | 1 |
| Michael | 1 |
| Michel | 1 |
| Michele | 1 |
| Microbiology | 1 |
| Midlands | 1 |
| Migliori | 1 |
| Miguel | 1 |
| Milano | 1 |
| Millicell | 1 |
| Millions | 1 |
| Min | 1 |
| Ming | 1 |
| Mining | 1 |
| Mechanisms | 1 |
| Mechanical | 1 |
| Nicolas | 1 |
| Measles | 1 |
| Marina | 1 |
| Marini | 1 |
| Mark | 1 |
| Marks | 1 |
| Marmoset | 1 |
| Marnix | 1 |
| Marquette | 1 |
| Marruchella | 1 |
| Martin | 1 |
| Martina | 1 |
| María | 1 |
| Mas | 1 |
| Masahiro | 1 |
| Mashan | 1 |
| Massimo | 1 |
| Mastermix | 1 |
| Mathieu | 1 |
| Matthew | 1 |
| Matthias | 1 |
| Maxima | 1 |
| McCabe | 1 |
| McCreesh | 1 |
| McQuaid | 1 |
| Mcstay | 1 |
| Mean | 1 |
| Minzhou | 1 |
| Mirandola | 1 |
| Mirko | 1 |
| Mitja | 1 |
| NCT04335136 | 1 |
| NEJM | 1 |
| NETs | 1 |
| NEWS | 1 |
| NHSX | 1 |
| NIH | 1 |
| NO2 | 1 |
| NPV | 1 |
| NRSs | 1 |